CYTK
$65.91+0.41%
as of close, Sep 30, 2026
☾ AH $65.91 +0.41%
Cytokinetics IncorporatedStock · Health CareRussell 2000 0.3%Nasdaq Composite 0.02%US Stock Market 0.02%Russell 3000 0.02%
Cytokinetics Incorporated returns by year
As of market close, Sep 30, 2026
Cytokinetics Incorporated returns by year (2005–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $63.54 | $65.91 | 0.0% | +3.7% | |
| 2025 | $47.04 | $63.54 | 0.0% | +35.1% | |
| 2024 | $83.49 | $47.04 | 0.0% | -43.7% | |
| 2023 | $45.82 | $83.49 | 0.0% | +82.2% | |
| 2022 | $45.58 | $45.82 | 0.0% | +0.5% | |
| 2021 | $20.78 | $45.58 | 0.0% | +119.3% | |
| 2020 | $10.61 | $20.78 | 0.0% | +95.9% | |
| 2019 | $6.32 | $10.61 | 0.0% | +67.9% | |
| 2018 | $8.15 | $6.32 | 0.0% | -22.5% | |
| 2017 | $12.15 | $8.15 | 0.0% | -32.9% | |
| 2016 | $10.46 | $12.15 | 0.0% | +16.2% | |
| 2015 | $8.01 | $10.46 | 0.0% | +30.6% | |
| 2014 | $6.50 | $8.01 | 0.0% | +23.2% | |
| 2013 | $3.96 | $6.50 | 0.0% | +64.1% | |
| 2012 | $5.76 | $3.96 | 0.0% | -31.3% | |
| 2011 | $12.54 | $5.76 | 0.0% | -54.1% | |
| 2010 | $17.46 | $12.54 | 0.0% | -28.2% | |
| 2009 | $17.10 | $17.46 | 0.0% | +2.1% | |
| 2008 | $28.38 | $17.10 | 0.0% | -39.7% | |
| 2007 | $44.88 | $28.38 | 0.0% | -36.8% | |
| 2006 | $39.12 | $44.88 | 0.0% | +14.7% | |
| 2005 | $61.50 | $39.12 | 0.0% | -36.4% |
- Annualized
- -1.7%
- 2005–2026
- Average year
- +10.8%
- 21 full years
- Best year
- +119.3%
- 2021
- Worst year
- -54.1%
- 2011
- Positive years
- 12/21
- 57% up
Annualized (CAGR)
-1.7%
2005–2026
Average year
+10.8%
21 full years
Best year
+119.3%
2021
Worst year
-54.1%
2011
Positive years
12/21
57% up
Total return by period#
Annual
-100%-50%0%50%100%
2005-36%'05
2006+15%
2007-37%'07
2008-40%
2009+2.1%'09
2010-28%
2011-54%'11
2012-31%
2013+64%'13
2014+23%
2015+31%'15
2016+16%
2017-33%'17
2018-22%
2019+68%'19
2020+96%
2021+119%'21
2022+0.53%
2023+82%'23
2024-44%
2025+35%'25
2026+3.7%
Methodology#
Total returns, dividends reinvested, measured on CYTK. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Cytokinetics Incorporated's average annual return?
- Since 2005, Cytokinetics Incorporated (CYTK) has returned about -1.7% a year (the compound annual growth rate) and an average calendar-year return of 10.8%.
- What were Cytokinetics Incorporated's best and worst years?
- Over 2005–2026, the best year was 2021 (+119.3%) and the worst was 2011 (-54.1%).
- How often is Cytokinetics Incorporated up in a year?
- 12 of the 21 full years since 2005 were positive — about 57% of the time.
More on Cytokinetics Incorporated
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100